Search research articles
Contact Us
Filters
Showing results (1-10 of 231) with videos related to
Page
of 24
Sort By:
Journal of Neurology
|
February 8, 2003
Diagnosis of hereditary neuropathies in adult patients
Davide Pareyson
Neurology
|
May 16, 2007
Axonal Charcot-Marie-Tooth disease: the fog is only slowly lifting
Davide Pareyson
Neuromuscular Disorders : NMD
|
July 16, 2023
Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease
Chiara Pisciotta, Davide Pareyson
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 10, 2023
The tip of the iceberg in ATTRv: when to start carrier monitoring and when to initiate treatment?
Davide Pareyson, Silvia Fenu
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 14, 2021
CMT2CC associated with <i>NEFH</i> mutations: a predominantly motor neuronopathy
Chiara Pisciotta, Davide Pareyson
The Lancet. Neurology
|
October 13, 2009
Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective?
Davide Pareyson, Alessandra Solari
Advances in Experimental Medicine and Biology
|
March 13, 2010
Natural history and treatment of peripheral inherited neuropathies
Davide Pareyson, Chiara Marchesi
The Lancet. Neurology
|
June 23, 2009
Diagnosis, natural history, and management of Charcot-Marie-Tooth disease
Davide Pareyson, Chiara Marchesi
Journal of Neurology
|
July 24, 2012
Clinical neurogenetics: recent advances
Davide Pareyson, Ettore Salsano
Journal of the Peripheral Nervous System : JPNS
|
June 7, 2022
Charcot-Marie-Tooth disease in Africa
Stephan Züchner, Davide Pareyson
Page
of 24
Search research articles
Search
Showing results (1-10 of 231) with videos related to
Sort By:
Page
of 24
Journal of Neurology
|
February 8, 2003
Diagnosis of hereditary neuropathies in adult patients
Davide Pareyson
Neurology
|
May 16, 2007
Axonal Charcot-Marie-Tooth disease: the fog is only slowly lifting
Davide Pareyson
Neuromuscular Disorders : NMD
|
July 16, 2023
Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease
Chiara Pisciotta, Davide Pareyson
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 10, 2023
The tip of the iceberg in ATTRv: when to start carrier monitoring and when to initiate treatment?
Davide Pareyson, Silvia Fenu
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 14, 2021
CMT2CC associated with <i>NEFH</i> mutations: a predominantly motor neuronopathy
Chiara Pisciotta, Davide Pareyson
The Lancet. Neurology
|
October 13, 2009
Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective?
Davide Pareyson, Alessandra Solari
Advances in Experimental Medicine and Biology
|
March 13, 2010
Natural history and treatment of peripheral inherited neuropathies
Davide Pareyson, Chiara Marchesi
The Lancet. Neurology
|
June 23, 2009
Diagnosis, natural history, and management of Charcot-Marie-Tooth disease
Davide Pareyson, Chiara Marchesi
Journal of Neurology
|
July 24, 2012
Clinical neurogenetics: recent advances
Davide Pareyson, Ettore Salsano
Journal of the Peripheral Nervous System : JPNS
|
June 7, 2022
Charcot-Marie-Tooth disease in Africa
Stephan Züchner, Davide Pareyson
Page
of 24